Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ars Pharmaceuticals, Inc. (SPRY) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ars Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1671858.
Total stock buying since 2020: $110,730,422.
Total stock sales since 2020: $121,181,311.
Total stock option exercises since 2020: $4,197,048.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 1,315,620 | $21,510,891 | 472,502 | $1,475,457 |
| 2024 | 1,401,299 | $13,289,409 | 7,578,789 | $96,080,153 | 1,518,295 | $2,086,596 |
| 2023 | 7,536,258 | $38,949,954 | 500,000 | $3,389,224 | 500,000 | $634,995 |
| 2022 | 0 | $0 | 43,896 | $201,043 | 0 | $0 |
| 2021 | 2,364 | $36,047 | 0 | $0 | 0 | $0 |
| 2020 | 2,783,572 | $58,455,012 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 112,500 | $1,615,584 | 12,500 | $18,750 |
| 2025-07 | 0 | $0 | 15,000 | $254,865 | 15,000 | $22,500 |
| 2025-06 | 0 | $0 | 755,149 | $13,903,150 | 15,000 | $22,500 |
| 2025-05 | 0 | $0 | 272,969 | $3,866,703 | 270,000 | $754,200 |
| 2025-04 | 0 | $0 | 50,002 | $615,074 | 50,002 | $242,509 |
| 2025-03 | 0 | $0 | 60,000 | $700,465 | 60,000 | $257,498 |
| 2025-01 | 0 | $0 | 50,000 | $555,050 | 50,000 | $157,500 |
| 2024-12 | 0 | $0 | 1,079,245 | $14,003,240 | 754,327 | $1,239,474 |
| 2024-11 | 0 | $0 | 1,063,270 | $17,656,506 | 0 | $0 |
| 2024-10 | 0 | $0 | 412,500 | $5,965,200 | 12,500 | $18,750 |
| 2024-09 | 0 | $0 | 410,000 | $5,026,000 | 10,000 | $15,000 |
| 2024-08 | 0 | $0 | 2,407,254 | $32,630,194 | 102,500 | $84,950 |
| 2024-07 | 0 | $0 | 300,000 | $3,242,300 | 0 | $0 |
| 2024-06 | 0 | $0 | 100,000 | $913,911 | 0 | $0 |
| 2024-05 | 0 | $0 | 800,000 | $7,417,302 | 0 | $0 |
| 2024-04 | 0 | $0 | 400,000 | $3,711,396 | 638,968 | $728,422 |
| 2024-03 | 1,401,299 | $13,289,409 | 400,000 | $3,651,134 | 0 | $0 |
| 2024-02 | 0 | $0 | 206,520 | $1,862,970 | 0 | $0 |
| 2023-09 | 2,786,258 | $9,499,954 | 100,000 | $770,500 | 100,000 | $127,000 |
| 2023-08 | 4,750,000 | $29,450,000 | 100,000 | $708,326 | 100,000 | $126,998 |
| 2023-07 | 0 | $0 | 100,000 | $646,824 | 100,000 | $126,998 |
| 2023-06 | 0 | $0 | 100,000 | $684,040 | 100,000 | $126,999 |
| 2023-05 | 0 | $0 | 100,000 | $579,534 | 100,000 | $127,000 |
| 2022-11 | 0 | $0 | 43,896 | $201,043 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | Scott Kathleen D. (Chief Financial Officer) | Sale | 12,500 | 15.00 | 187,500 |
| 2025-08-21 | Scott Kathleen D. (Chief Financial Officer) | Option Ex | 12,500 | 1.50 | 18,750 |
| 2025-08-21 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 50,000 | 14.49 | 724,350 |
| 2025-08-20 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 37,656 | 14.09 | 530,610 |
| 2025-08-19 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 12,344 | 14.03 | 173,124 |
| 2025-07-01 | Karas Eric (Chief Commercial Officer) | Sale | 15,000 | 16.99 | 254,865 |
| 2025-07-01 | Karas Eric (Chief Commercial Officer) | Option Ex | 15,000 | 1.50 | 22,500 |
| 2025-06-27 | Deerfield Private Design Fund Iv, L.p. | Sale | 740,149 | 18.46 | 13,663,150 |
| 2025-06-18 | Karas Eric (Chief Commercial Officer) | Sale | 15,000 | 16.00 | 240,000 |
| 2025-06-18 | Karas Eric (Chief Commercial Officer) | Option Ex | 15,000 | 1.50 | 22,500 |
| 2025-05-20 | Scott Kathleen D. (Chief Financial Officer) | Sale | 50,000 | 14.10 | 705,150 |
| 2025-05-20 | Scott Kathleen D. (Chief Financial Officer) | Option Ex | 50,000 | 1.50 | 75,000 |
| 2025-05-20 | Fitzpatrick Alexander A (Chief Legal Officer) | Sale | 102,969 | 14.10 | 1,451,553 |
| 2025-05-20 | Fitzpatrick Alexander A (Chief Legal Officer) | Option Ex | 100,000 | 5.58 | 558,000 |
| 2025-05-20 | Saunders Brent L | Sale | 120,000 | 14.25 | 1,710,000 |
| 2025-05-20 | Saunders Brent L | Option Ex | 120,000 | 1.01 | 121,200 |
| 2025-04-07 | Shawver Laura | Sale | 50,002 | 12.30 | 615,074 |
| 2025-04-07 | Shawver Laura | Option Ex | 50,002 | 4.85 | 242,509 |
| 2025-03-20 | Karas Eric (Chief Commercial Officer) | Sale | 10,000 | 14.00 | 140,000 |
| 2025-03-20 | Karas Eric (Chief Commercial Officer) | Option Ex | 10,000 | 1.50 | 15,000 |
| 2025-03-06 | Shawver Laura | Sale | 49,600 | 11.21 | 556,065 |
| 2025-03-06 | Shawver Laura | Option Ex | 49,600 | 4.85 | 240,559 |
| 2025-03-05 | Shawver Laura | Sale | 400 | 11.00 | 4,400 |
| 2025-03-05 | Shawver Laura | Option Ex | 400 | 4.85 | 1,939 |
| 2025-01-06 | Shawver Laura | Sale | 50,000 | 11.10 | 555,050 |
| 2025-01-06 | Shawver Laura | Option Ex | 50,000 | 3.15 | 157,500 |
| 2024-12-17 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 11.67 | 1,167,100 |
| 2024-12-17 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 11.67 | 1,167,100 |
| 2024-12-13 | Chakma Justin (Chief Business Officer) | Sale | 27,272 | 12.06 | 328,982 |
| 2024-12-13 | Chakma Justin (Chief Business Officer) | Option Ex | 27,272 | 1.44 | 39,271 |
| 2024-12-12 | Chakma Justin (Chief Business Officer) | Sale | 117,333 | 12.27 | 1,439,089 |
| 2024-12-12 | Chakma Justin (Chief Business Officer) | Option Ex | 117,333 | .84 | 98,559 |
| 2024-12-12 | Dorsey Brian (Chief Operating Officer) | Sale | 25,000 | 12.30 | 307,425 |
| 2024-12-12 | Dorsey Brian (Chief Operating Officer) | Option Ex | 25,000 | .64 | 16,000 |
| 2024-12-11 | Dorsey Brian (Chief Operating Officer) | Sale | 15,000 | 12.43 | 186,420 |
| 2024-12-11 | Dorsey Brian (Chief Operating Officer) | Option Ex | 15,000 | .64 | 9,600 |
| 2024-12-10 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 13.16 | 1,316,400 |
| 2024-12-10 | Chakma Justin (Chief Business Officer) | Sale | 50,000 | 13.15 | 657,650 |
| 2024-12-10 | Chakma Justin (Chief Business Officer) | Option Ex | 50,000 | .84 | 42,000 |
| 2024-12-10 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 13.16 | 1,316,400 |
| 2024-12-06 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Option Ex | 37,541 | 6.09 | 228,737 |
| 2024-12-06 | Chakma Justin (Chief Business Officer) | Sale | 50,000 | 14.23 | 711,600 |
| 2024-12-06 | Chakma Justin (Chief Business Officer) | Option Ex | 50,000 | .84 | 42,000 |
| 2024-12-06 | Lowenthal Richard E (PRESIDENT AND CEO) | Option Ex | 37,541 | 6.09 | 228,737 |
| 2024-12-05 | Chakma Justin (Chief Business Officer) | Sale | 49,640 | 14.13 | 701,661 |
| 2024-12-05 | Chakma Justin (Chief Business Officer) | Option Ex | 49,640 | .84 | 41,697 |
| 2024-12-04 | Karas Eric (Chief Commercial Officer) | Sale | 6,283 | 14.00 | 87,962 |
| 2024-12-04 | Karas Eric (Chief Commercial Officer) | Option Ex | 6,283 | 1.50 | 9,424 |
| 2024-12-04 | Chakma Justin (Chief Business Officer) | Sale | 45,000 | 13.95 | 627,930 |
| 2024-12-04 | Chakma Justin (Chief Business Officer) | Option Ex | 45,000 | .84 | 37,800 |
| 2024-12-04 | Shawver Laura | Sale | 14,772 | 13.75 | 203,115 |
| 2024-12-04 | Shawver Laura | Option Ex | 14,772 | 3.15 | 46,531 |
| 2024-12-03 | Chakma Justin (Chief Business Officer) | Sale | 45,000 | 13.19 | 593,415 |
| 2024-12-03 | Chakma Justin (Chief Business Officer) | Option Ex | 45,000 | .84 | 37,800 |
| 2024-12-03 | Shawver Laura | Sale | 87,984 | 13.26 | 1,166,931 |
| 2024-12-03 | Shawver Laura | Option Ex | 87,984 | 2.21 | 194,444 |
| 2024-12-02 | Karas Eric (Chief Commercial Officer) | Sale | 3,717 | 14.11 | 52,461 |
| 2024-12-02 | Karas Eric (Chief Commercial Officer) | Option Ex | 3,717 | 1.50 | 5,575 |
| 2024-12-02 | Chakma Justin (Chief Business Officer) | Sale | 45,000 | 13.67 | 615,240 |
| 2024-12-02 | Chakma Justin (Chief Business Officer) | Option Ex | 45,000 | .84 | 37,800 |
| 2024-12-02 | Shawver Laura | Sale | 97,244 | 13.95 | 1,356,359 |
| 2024-12-02 | Shawver Laura | Option Ex | 97,244 | 1.27 | 123,499 |
| 2024-11-27 | Chakma Justin (Chief Business Officer) | Sale | 25,000 | 14.39 | 359,750 |
| 2024-11-26 | Chakma Justin (Chief Business Officer) | Sale | 42,186 | 14.05 | 592,586 |
| 2024-11-25 | Chakma Justin (Chief Business Officer) | Sale | 32,814 | 14.00 | 459,428 |
| 2024-11-19 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 13.95 | 1,395,000 |
| 2024-11-19 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 13.95 | 1,395,000 |
| 2024-11-12 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 17.20 | 1,720,100 |
| 2024-11-12 | Deerfield Private Design Fund Iv, L.p. | Sale | 34,814 | 17.46 | 608,026 |
| 2024-11-12 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 17.20 | 1,720,100 |
| 2024-11-11 | Deerfield Private Design Fund Iv, L.p. | Sale | 528,456 | 17.80 | 9,406,516 |
| 2024-10-16 | Scott Kathleen D. (Chief Financial Officer) | Sale | 12,500 | 16.00 | 200,000 |
| 2024-10-16 | Scott Kathleen D. (Chief Financial Officer) | Option Ex | 12,500 | 1.50 | 18,750 |
| 2024-10-15 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 15.00 | 1,499,800 |
| 2024-10-15 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 15.00 | 1,499,800 |
| 2024-10-08 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 13.83 | 1,382,800 |
| 2024-10-08 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 13.83 | 1,382,800 |
| 2024-09-18 | Karas Eric (Chief Commercial Officer) | Sale | 10,000 | 14.00 | 140,000 |
| 2024-09-18 | Karas Eric (Chief Commercial Officer) | Option Ex | 10,000 | 1.50 | 15,000 |
| 2024-09-17 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 12.93 | 1,293,200 |
| 2024-09-17 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 12.93 | 1,293,200 |
| 2024-09-10 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 11.50 | 1,149,800 |
| 2024-09-10 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 11.50 | 1,149,800 |
| 2024-08-26 | Thompson Peter A. | Sale | 83,695 | 13.00 | 1,088,035 |
| 2024-08-26 | Orbimed Capital Llc | Sale | 83,695 | 13.00 | 1,088,035 |
| 2024-08-23 | Thompson Peter A. | Sale | 69,500 | 13.03 | 905,585 |
| 2024-08-23 | Orbimed Capital Llc | Sale | 69,500 | 13.03 | 905,585 |
| 2024-08-22 | Thompson Peter A. | Sale | 391,482 | 12.94 | 5,065,777 |
| 2024-08-22 | Orbimed Capital Llc | Sale | 391,482 | 12.94 | 5,065,777 |
| 2024-08-21 | Thompson Peter A. | Sale | 407,700 | 14.06 | 5,734,300 |
| 2024-08-21 | Orbimed Capital Llc | Sale | 407,700 | 14.06 | 5,734,300 |
| 2024-08-20 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 15.54 | 1,554,400 |
| 2024-08-20 | Scott Kathleen D. (Chief Financial Officer) | Sale | 12,500 | 16.00 | 200,000 |
| 2024-08-20 | Scott Kathleen D. (Chief Financial Officer) | Option Ex | 12,500 | 1.50 | 18,750 |
| 2024-08-20 | Dorsey Brian (Chief Operating Officer) | Sale | 50,000 | 15.00 | 750,000 |
| 2024-08-20 | Dorsey Brian (Chief Operating Officer) | Option Ex | 50,000 | .64 | 32,000 |
| 2024-08-20 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 15.54 | 1,554,400 |
| 2024-08-19 | Karas Eric (Chief Commercial Officer) | Sale | 10,000 | 14.00 | 140,000 |
| 2024-08-19 | Karas Eric (Chief Commercial Officer) | Option Ex | 10,000 | 1.50 | 15,000 |
| 2024-08-13 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 12.27 | 1,227,000 |
| 2024-08-13 | Dorsey Brian (Chief Operating Officer) | Sale | 30,000 | 13.00 | 390,000 |
| 2024-08-13 | Dorsey Brian (Chief Operating Officer) | Option Ex | 30,000 | .64 | 19,200 |
| 2024-08-13 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 12.27 | 1,227,000 |
| 2024-07-16 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 11.40 | 1,140,300 |
| 2024-07-16 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 11.40 | 1,140,300 |
| 2024-07-09 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 9.62 | 961,700 |
| 2024-06-12 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 95,862 | 9.14 | 876,657 |
| 2024-06-11 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 4,138 | 9.00 | 37,254 |
| 2024-05-16 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 89,096 | 9.06 | 807,031 |
| 2024-05-16 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 89,096 | 9.06 | 807,031 |
| 2024-05-15 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 5,147 | 9.05 | 46,570 |
| 2024-05-15 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 5,147 | 9.05 | 46,570 |
| 2024-05-14 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 5,757 | 9.01 | 51,853 |
| 2024-05-14 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 5,757 | 9.01 | 51,853 |
| 2024-05-07 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 200,000 | 9.34 | 1,868,798 |
| 2024-05-07 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 200,000 | 9.34 | 1,868,798 |
| 2024-04-23 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Option Ex | 130,993 | 1.14 | 149,332 |
| 2024-04-23 | Lowenthal Richard E (PRESIDENT AND CEO) | Option Ex | 130,993 | 1.14 | 149,332 |
| 2024-04-19 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Option Ex | 188,491 | 1.14 | 214,879 |
| 2024-04-19 | Lowenthal Richard E (PRESIDENT AND CEO) | Option Ex | 188,491 | 1.14 | 214,879 |
| 2024-04-16 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 9.28 | 927,999 |
| 2024-04-16 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 9.28 | 927,999 |
| 2024-04-09 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 100,000 | 9.28 | 927,699 |
| 2024-04-09 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 100,000 | 9.28 | 927,699 |
| 2024-03-27 | Shah Rajeev M. | Buy | 505,954 | 9.79 | 4,953,289 |
| 2024-03-26 | Shah Rajeev M. | Buy | 457,745 | 9.55 | 4,371,464 |
| 2024-03-25 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 95,267 | 9.12 | 869,216 |
| 2024-03-25 | Shah Rajeev M. | Buy | 437,600 | 9.06 | 3,964,656 |
| 2024-03-25 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 95,267 | 9.12 | 869,216 |
| 2024-03-22 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 2,343 | 9.02 | 21,138 |
| 2024-03-22 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 2,343 | 9.02 | 21,138 |
| 2024-03-21 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 472 | 9.00 | 4,248 |
| 2024-03-21 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 472 | 9.00 | 4,248 |
| 2024-03-19 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 1,918 | 9.03 | 17,323 |
| 2024-03-19 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 1,918 | 9.03 | 17,323 |
| 2024-03-15 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 96,756 | 9.14 | 884,446 |
| 2024-03-15 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 96,756 | 9.14 | 884,446 |
| 2024-03-14 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 444 | 9.00 | 3,996 |
| 2024-03-14 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 444 | 9.00 | 3,996 |
| 2024-03-13 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 2,800 | 9.00 | 25,200 |
| 2024-03-13 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 2,800 | 9.00 | 25,200 |
| 2024-02-29 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 3,782 | 9.02 | 34,102 |
| 2024-02-29 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 3,782 | 9.02 | 34,102 |
| 2024-02-28 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 98,778 | 9.02 | 891,076 |
| 2024-02-28 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 98,778 | 9.02 | 891,076 |
| 2024-02-26 | Tanimoto Sarina (CHIEF MEDICAL OFFICER) | Sale | 700 | 9.01 | 6,307 |
| 2024-02-26 | Lowenthal Richard E (PRESIDENT AND CEO) | Sale | 700 | 9.01 | 6,307 |
| 2023-09-29 | Fitzpatrick Alexander A (Chief Legal Officer) | Buy | 46,258 | 3.78 | 174,994 |
| 2023-09-28 | Fitzpatrick Alexander A (Chief Legal Officer) | Buy | 40,000 | 3.62 | 144,960 |
| 2023-09-21 | Shah Rajeev M. | Buy | 2,700,000 | 3.40 | 9,180,000 |
| 2023-09-01 | Shawver Laura (Director) | Sale | 100,000 | 7.71 | 770,500 |
| 2023-09-01 | Shawver Laura (Director) | Option Ex | 100,000 | 1.27 | 127,000 |
| 2023-08-29 | Shah Rajeev M. | Buy | 3,750,000 | 6.20 | 23,250,000 |
| 2023-08-29 | Thompson Peter A. | Buy | 500,000 | 6.20 | 3,100,000 |
| 2023-08-29 | Orbimed Capital Llc | Buy | 500,000 | 6.20 | 3,100,000 |
| 2023-08-04 | Shawver Laura (Director) | Sale | 18,897 | 7.06 | 133,469 |
| 2023-08-04 | Shawver Laura (Director) | Option Ex | 18,897 | 1.27 | 23,999 |
| 2023-08-03 | Shawver Laura (Director) | Sale | 26,107 | 7.01 | 183,010 |
| 2023-08-03 | Shawver Laura (Director) | Option Ex | 26,107 | 1.27 | 33,155 |
| 2023-08-02 | Shawver Laura (Director) | Sale | 36,281 | 7.09 | 257,268 |
| 2023-08-02 | Shawver Laura (Director) | Option Ex | 36,281 | 1.27 | 46,076 |
| 2023-08-01 | Shawver Laura (Director) | Sale | 18,715 | 7.19 | 134,579 |
| 2023-08-01 | Shawver Laura (Director) | Option Ex | 18,715 | 1.27 | 23,768 |
| 2023-07-07 | Shawver Laura (Director) | Sale | 8,858 | 6.36 | 56,372 |
| 2023-07-07 | Shawver Laura (Director) | Option Ex | 8,858 | 1.27 | 11,249 |
| 2023-07-06 | Shawver Laura (Director) | Sale | 33,510 | 6.34 | 212,553 |
| 2023-07-06 | Shawver Laura (Director) | Option Ex | 33,510 | 1.27 | 42,557 |
| 2023-07-05 | Shawver Laura (Director) | Sale | 31,112 | 6.41 | 199,552 |
| 2023-07-05 | Shawver Laura (Director) | Option Ex | 31,112 | 1.27 | 39,512 |
| 2023-07-03 | Shawver Laura (Director) | Sale | 26,520 | 6.72 | 178,347 |
| 2023-07-03 | Shawver Laura (Director) | Option Ex | 26,520 | 1.27 | 33,680 |
| 2023-06-02 | Shawver Laura (Director) | Sale | 26,941 | 6.95 | 187,239 |
| 2023-06-02 | Shawver Laura (Director) | Option Ex | 26,941 | 1.27 | 34,215 |
| 2023-06-01 | Shawver Laura (Director) | Sale | 73,059 | 6.80 | 496,801 |
| 2023-06-01 | Shawver Laura (Director) | Option Ex | 73,059 | 1.27 | 92,784 |
| 2023-05-09 | Shawver Laura (Director) | Sale | 42,900 | 5.31 | 227,798 |
| 2023-05-09 | Shawver Laura (Director) | Option Ex | 42,900 | 1.27 | 54,483 |
| 2023-05-08 | Shawver Laura (Director) | Sale | 57,100 | 6.16 | 351,736 |
| 2023-05-08 | Shawver Laura (Director) | Option Ex | 57,100 | 1.27 | 72,517 |
| 2022-11-09 | Shawver Laura (Director) | Sale | 43,896 | 4.58 | 201,043 |
| 2021-11-15 | Root Jonathan D (Director) | Buy | 2,014 | 8.85 | 17,823 |
| 2021-03-03 | Root Jonathan D (Director) | Buy | 350 | 52.07 | 18,224 |
| 2020-12-08 | Piazza Jonathan (Chief Financial Officer) | Buy | 11,904 | 21.00 | 249,984 |
| 2020-12-08 | Hawkinson Russ (Sr. Vice President of Finance) | Buy | 238 | 21.00 | 4,998 |
| 2020-12-08 | Schroeder Thilo (Director) | Buy | 238,096 | 21.00 | 5,000,016 |
| 2020-12-08 | Tansey Casey M | Buy | 47,619 | 21.00 | 999,999 |
| 2020-12-08 | Thompson Peter A. (Director) | Buy | 1,190,477 | 21.00 | 25,000,017 |
| 2020-12-08 | Capps Vickie L (Director) | Buy | 9,523 | 21.00 | 199,983 |
| 2020-12-08 | Root Jonathan D (Director) | Buy | 95,238 | 21.00 | 1,999,998 |
| 2020-12-08 | Orbimed Capital Llc (Director) | Buy | 1,190,477 | 21.00 | 25,000,017 |
Insider trading activities including stock purchases, stock sales, and option exercises of SPRY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ars Pharmaceuticals, Inc. (symbol SPRY, CIK number 1671858) see the Securities and Exchange Commission (SEC) website.